Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jan 2009. Module: SNOMED CT core module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 471971018 | Vaginal dinoprostone | en | Synonym | Inactive | Only initial character case insensitive | SNOMED CT core module |
| 726134010 | Vaginal dinoprostone (substance) | en | Fully specified name | Inactive | Only initial character case insensitive | SNOMED CT core module |
| 1194259018 | Vaginal dinoprostone (product) | en | Fully specified name | Inactive | Only initial character case insensitive | SNOMED CT core module |
| 3288550013 | Vaginal form dinoprostone | en | Synonym | Inactive | Only initial character case insensitive | SNOMED CT core module |
| 3288569015 | Vaginal form dinoprostone (product) | en | Fully specified name | Inactive | Only initial character case insensitive | SNOMED CT core module |
| 3484910010 | Product containing dinoprostone in vaginal dosage form (medicinal product form) | en | Fully specified name | Inactive | Entire term case insensitive | SNOMED CT core module |
| 3493293011 | Product containing dinoprostone in vaginal dosage form | en | Synonym | Inactive | Entire term case insensitive | SNOMED CT core module |
| 3493294017 | Dinoprostone in vaginal dosage form | en | Synonym | Inactive | Entire term case insensitive | SNOMED CT core module |
| 3709621014 | Dinoprostone-containing product in vaginal dose form | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module |
| 3709622019 | Product containing dinoprostone in vaginal dose form (medicinal product form) | en | Fully specified name | Active | Entire term case insensitive | SNOMED CT core module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing dinoprostone in vaginal dose form (medicinal product form) | Is a | Product containing dinoprostone | true | Inferred relationship | Existential restriction modifier | ||
| Product containing dinoprostone in vaginal dose form (medicinal product form) | Has active ingredient | Prostaglandin PGE>2< | false | Inferred relationship | Existential restriction modifier | ||
| Product containing dinoprostone in vaginal dose form (medicinal product form) | Has active ingredient | Prostaglandin E>1< | false | Inferred relationship | Existential restriction modifier | ||
| Product containing dinoprostone in vaginal dose form (medicinal product form) | Has active ingredient | Dinoprostone | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing dinoprostone in vaginal dose form (medicinal product form) | Has active ingredient | Posterior pituitary hormone | false | Inferred relationship | Existential restriction modifier | ||
| Product containing dinoprostone in vaginal dose form (medicinal product form) | Has active ingredient | Alprostadil | false | Inferred relationship | Existential restriction modifier | ||
| Product containing dinoprostone in vaginal dose form (medicinal product form) | Is a | Product manufactured as vaginal dose form | true | Inferred relationship | Existential restriction modifier | ||
| Product containing dinoprostone in vaginal dose form (medicinal product form) | Has manufactured dose form | Vaginal dose form | true | Inferred relationship | Existential restriction modifier | ||
| Product containing dinoprostone in vaginal dose form (medicinal product form) | Plays role | Oxytocic therapeutic role | true | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets
FHIR